Favorite tweets

Don’t be misled—US is not withholding raw materials for any current vaccine in India. “Covishield” (aka AstraZeneca) is not affected.

The raw material shortage only affects “Covovax” (Novavax) which has not yet been approved anyway. #COVID19 #CovidIndiapic.twitter.com/NEEb8p2njh

— Eric Feigl-Ding (@DrEricDing) April 25, 2021

via Twitter https://twitter.com/DrEricDing

April 25, 2021 at 06:19PM